Senolytics and Chronic Inflammation: Reversing Inflammaging

Expert Summary

Inflammaging (chronic age-related systemic inflammation) contributes to virtually every major chronic disease of aging: cardiovascular disease, type 2 diabetes, neurodegeneration, cancer, sarcopenia, and osteoporosis. Senescent cells are one of the primary sources of inflammaging via persistent SASP secretion. Reducing senescent cell burden measurably reduces systemic inflammatory markers.

Key Facts

As an Amazon Associate, Stacking Years earns from qualifying purchases.

Thorne Quercetin Phytosome

250 mg quercetin phytosome per capsule

Quercetin phytosome capsules.

Best for: comparing a quercetin phytosome option in Key Facts

View on Amazon · Affiliate link

Life Extension Bio-Fisetin

8 mg fisetin per capsule

Low-dose fisetin with fenugreek galactomannans.

Best for: reviewing a low-dose fisetin label in Key Facts

View on Amazon · Affiliate link

Frequently Asked Questions

How quickly do inflammatory markers fall after senolytics?

In clinical trials, SASP-related markers (IL-6, MMP-3) begin declining within the first week post-treatment. The reduction continues over 2–4 weeks as dead senescent cells are cleared by phagocytes. hsCRP typically decreases within 2–4 weeks.

Can senolytics normalize CRP to below 1 mg/L?

In individuals with CRP elevated primarily from senescent cell SASP (rather than active infection, autoimmune disease, or other causes), senolytics can be sufficient to bring CRP to optimal range. Results depend on baseline senescent cell burden and the comprehensiveness of the senolytic protocol.

Get the free Longevity Supplement Starter Guide

Sign up for the guide and occasional Stacking Years updates. The guide is available on the confirmation screen.

Scientific References